Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
154.2 EUR | -1.46% |
|
+0.74% | +10.08% |
07-12 | AbbVie Submits FDA, EMA Applications for Upadacitinib to Treat Giant Cell Arteritis | MT |
07-12 | AbbVie Seeks U.S., Europe OK of Rinvoq in Giant Cell Arteritis | DJ |
Quotes 5-day view
Delayed Quote Xetra2024-07-10 | 2024-07-11 | 2024-07-12 | 2024-07-15 | |
---|---|---|---|---|
Last | 154.88 € | 156.24 € | 156.5 € | 154.22 € |
Volume | 645 | 124 | 397 | 781 |
Change | -0.08% | +0.88% | +0.17% | -1.46% |
Opening | 155.08 | 155.36 | 156.66 | 155.62 |
High | 156.32 | 156.24 | 157.90 | 156.06 |
Low | 153.58 | 154.50 | 155.22 | 154.22 |
Performance
1 day | -1.46% | ||
1 week | +0.74% | ||
Current month | -2.71% | ||
1 month | -2.17% | ||
3 months | +1.26% | ||
6 months | +3.71% | ||
Current year | +10.08% | ||
1 year | +28.09% | ||
3 years | +56.19% | ||
5 years | +90.51% |
Volumes
marketsBasic data
Highs and lows
![Extreme 152.34](/images/extremecours_fleche.png)
![Extreme 151.44](/images/extremecours_fleche.png)
![Extreme 140.2](/images/extremecours_fleche.png)
![Extreme 119.2](/images/extremecours_fleche.png)
![Extreme 90](/images/extremecours_fleche.png)
![Extreme 57.8](/images/extremecours_fleche.png)
![Extreme 41](/images/extremecours_fleche.png)
Indicators
Sector Comparison - Other Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-1.46% | +0.74% | +10.08% | +28.09% | 301B | ||
+0.22% | +3.54% | +63.05% | +111.47% | 854B | ||
-0.71% | -0.07% | +39.42% | +83.05% | 636B | ||
-0.43% | +2.58% | -4.78% | -6.65% | 361B | ||
+0.28% | +1.86% | +17.52% | +19.36% | 324B | ||
-1.27% | +0.40% | +14.19% | +17.24% | 247B | ||
+1.53% | +6.33% | +5.81% | -4.61% | 230B | ||
-0.96% | +2.58% | +16.77% | +16.64% | 228B | ||
-0.21% | +6.00% | +14.63% | +45.17% | 177B | ||
+0.62% | +4.19% | +1.08% | -19.88% | 164B | ||
-2.09% | +0.36% | +2.97% | -1.36% | 129B | ||
+1.21% | +4.83% | -12.59% | -8.27% | 87.16B | ||
-0.77% | +0.40% | -21.75% | -35.18% | 82.02B | ||
+1.55% | +4.27% | +57.00% | +55.75% | 72.4B | ||
-1.83% | -0.36% | +15.52% | +57.91% | 65.49B | ||
-.--% | +1.73% | - | - | 63.66B | ||
Average | -0.29% | +3.00% | +14.59% | +23.92% | ||
Weighted average by Cap. | -0.29% | +2.76% | +25.26% | +44.50% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Last transactions
Date | Price | Volume | Daily volume |
---|---|---|---|
11:35:46 | 154.2 | 26 | 781 |
11:26:35 | 154.4 | 2 | 755 |
11:26:35 | 154.3 | 50 | 753 |
10:37:05 | 154.8 | 2 | 703 |
10:26:33 | 155.3 | 2 | 701 |
09:53:48 | 155.8 | 3 | 699 |
09:39:01 | 155.1 | 18 | 696 |
09:31:37 | 154.4 | 200 | 678 |
09:31:37 | 154.6 | 8 | 478 |
09:06:14 | 154.9 | 7 | 470 |
Monthly variations
Annual change
2024 | +10.08% | ||
2023 | -7.88% | ||
2022 | +27.48% | ||
2021 | +39.42% | ||
2020 | +9.42% | ||
2019 | -3.40% | ||
2018 | -0.83% | ||
2017 | +35.78% | ||
2016 | +11.81% | ||
2015 | -0.85% | ||
2014 | +21.14% |
- Stock Market
- Equities
- ABBV Stock
- 4AB Stock
- Quotes AbbVie Inc.